lobbying_activities: 1147235

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1147235	203cd8bb-e3ac-417c-80f1-be21e6b479f8	Q3	THE PETRIZZO GROUP, INC.	305932	SAGE THERAPEUTICS, INC.	2011	third_quarter	MED	Advocated for federal funding to support development of neuroactive steroids to yield therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain.	Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2011-10-12T13:34:30.983000-04:00